STOWELINK CPO IN EXCLUSIVE INTERVIEW WITH KUTV ON TESTICULAR CANCER

In line with the Testicular Cancer Awareness Month, our CPO, Mr. Oduor Kevin was interviewed by KUTV to shed more light on this type of cancer which is less talked about yet is a common cancer among men. Testicular Cancer Awareness Month is observed annually in April to encourage men between the ages of 20 to 35 to get tested for testicular cancer. The month also doubles as a time to reflect on advancements in research, treatment, and progress.

Testicular cancer occurs when cancerous cells develop in the tissues of a testicles. The development of cancerous cells in both testicles can occur, but is very rare. Testicular cancer is the most common cancer in men aged 20 to 35. The disease usually is curable.  According to Cleveland Clinic, there are two primary types of testicular cancers: seminoma and non-seminoma. Seminoma arises from young germ cells, grows slowly, and stays relatively immobile. Between 30 percent and 40 percent of testicular cancers are seminomas. Non-seminoma evolves from more mature germ cells These tend to be more aggressive tumors. There are also testicular cancers that are a blend of both seminoma and non-seminoma.

During this wide-ranging interview, Mr. Oduor talked about:

• The signs and symptoms of testicular cancer
• The difference between testicular cancer and prostate cancer
• The burden of testicular cancer
• Diagnosis
• Why testicular is common in young people between the ages 20-35
• And the reasons why testicular cancer is highly treatable.

In ending this illuminating interview, Oduor shared about the award we won during the Quality Healthcare Kenyan Award in the Innovation Project of the Year through our NCDs365 project. He talked about how the award was an inspiration and motivation for Stowelink to continue impacting lives and improving the health outcomes of our beneficiaries.

Here is the full interview for you to watch. Please like and leave a comment. Thank you!

Embed this YouTube link